These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23336815)

  • 1. Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease.
    Kurata T; Miyazaki K; Morimoto N; Kawai H; Ohta Y; Ikeda Y; Abe K
    Neurol Res; 2013 Mar; 35(2):193-205. PubMed ID: 23336815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer's disease.
    Kurata T; Miyazaki K; Kozuki M; Morimoto N; Ohta Y; Ikeda Y; Abe K
    Neurol Res; 2012 Jul; 34(6):601-10. PubMed ID: 22732109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain.
    Kurata T; Kawai H; Miyazaki K; Kozuki M; Morimoto N; Ohta Y; Ikeda Y; Abe K
    J Neurol Sci; 2012 Nov; 322(1-2):59-63. PubMed ID: 22795384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin.
    Kurata T; Miyazaki K; Kozuki M; Morimoto N; Ohta Y; Ikeda Y; Abe K
    Neuroscience; 2011 Dec; 197():358-68. PubMed ID: 21955601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α.
    Kozuki M; Kurata T; Miyazaki K; Morimoto N; Ohta Y; Ikeda Y; Abe K
    Brain Res; 2011 May; 1388():32-8. PubMed ID: 21419111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
    Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
    J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.
    Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R
    Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
    Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
    Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.
    Poolsup N; Suksomboon N; Wongyaowarat K; Rungkanchananon B; Niyomrat P; Kongsuwan S
    J Clin Pharm Ther; 2012 Apr; 37(2):166-72. PubMed ID: 21585411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.
    Koladiya RU; Jaggi AS; Singh N; Sharma BK
    BMC Pharmacol; 2008 Aug; 8():14. PubMed ID: 18691432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia.
    Nakagomi A; Shibui T; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
    J Atheroscler Thromb; 2015; 22(11):1158-71. PubMed ID: 26084792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
    Diepeveen SH; Verhoeven GW; Van Der Palen J; Dikkeschei LD; Van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
    J Intern Med; 2005 May; 257(5):438-45. PubMed ID: 15836660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
    Ogata N; Fujimori S; Oka Y; Kaneko K
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):321-4. PubMed ID: 20544514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.